Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology

@article{Hartogsohn2016SetAS,
  title={Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology},
  author={Ido Hartogsohn},
  journal={Journal of Psychopharmacology},
  year={2016},
  volume={30},
  pages={1259 - 1267}
}
  • Ido Hartogsohn
  • Published 16 November 2016
  • Medicine, Psychology
  • Journal of Psychopharmacology
Placebo response theory and set and setting theory are two fields which examine how non-biological factors shape the response to therapy. Both consider factors such as expectancy, preparation and beliefs to be crucial for understanding the extra-pharmacological processes which shape the response to drugs. Yet there are also fundamental differences between the two theories. Set and setting concerns itself with response to psychoactive drugs only; placebo theory relates to all therapeutic… 

Tables from this paper

Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy

Four major contextual "common factors" shared by various healing traditions are examined: 1) the therapeutic relationship; 2) the healing setting; 3) the rationale, conceptual scheme, or myth; and 4) the ritual.

Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default

The acute subjective effects of psychedelics are responsive to users’ expectations and surroundings (i.e., “set and setting”). Accordingly, a great deal of thought has gone into designing the

Psychedelics and Psychotherapy.

A framework for understanding why psychedelics are likely to be effective with very diverse types of psychotherapies is created and some common conceptual vocabulary is provided that can be used to frame therapeutic psychedelic effects beyond the confines of any one specific modality.

Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology

Langlitz and colleagues wrote about clinically used psychedelic drugs and the possibility of a “moral psychopharmacology” earlier in this journal (1). They emphasized the context-dependency of the

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics

The case for a moral psychopharmacology of psychedelics is made that examines whether psychedelics serve as non-specific amplifiers that enable subjects to (re-)connect with their values, or whether they promote specific moral-political orientations such as liberal and anti-authoritarian views, as recent studies suggest.

Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy

Purpose of Review The use of psychedelics in a therapeutical setting has been reported for the treatment of various diagnoses in recent years. However, as psychedelic substances are still commonly

Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

Psychedelic research continues to garner significant public and scientific interest with a growing number of clinical studies examining a wide range of conditions and disorders. However, expectancy

Set and setting in microdosing: an oft-overlooked principle

Why set and setting are of crucial importance in the case of microdosing is explained and reasoning helps elucidate the role of set andSetting in determining the outcomes ofmicrodosing and helps explain some of the contradictory results that have emerged in microdoses research in recent years.

Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy

A framework for investigating the neurobiological basis of PAP is offered by extrapolating from models used to explain how a pharmacologic intervention might create an optimal brain state during which environmental input has enduring effects.

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

An overview of past and present models of psychedelic therapy is provided, and important considerations for future interventions incorporating the use of psychedelics in research and clinical practice are discussed.
...

References

SHOWING 1-10 OF 130 REFERENCES

Endogenous opiates and the placebo effect: a meta-analytic review.

Placebo, Prozac and PLoS: significant lessons for psychopharmacology

Kirsch et al. (2008, Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5: e45), conducted a meta-analysis of data from 35

Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication

Examination of pre–post effect sizes among depressed individuals assigned to no-treatment or wait-list control groups suggest that approximately one quarter of the drug response is due to the administration of an active medication, one half is a placebo effect, and the remaining quarter isdue to other nonspecific factors.

Components of Placebo Effect: Randomised Controlled Trial in Patients with Irritable Bowel Syndrome

Whether placebo effects can experimentally be separated into the response to three components—assessment and observation, a therapeutic ritual, and a supportive patient-practitioner relationship—and then progressively combined to produce incremental clinical improvement in patients with irritable bowel syndrome is investigated.

Placebo, belief, and health. A cognitive-emotional model.

  • L. Lundh
  • Psychology
    Scandinavian journal of psychology
  • 1987
It is argued that an important part of the placebo effect is due to the development of placebo beliefs, which may counteract the kind of cognitions that produce anxiety and depression; placebo beliefs produce emotional responses (hope, calm, etc.), which are antagonistic to depression and anxiety.

Goal activation, expectations, and the placebo effect.

It is predicted that the placebo effect is most likely to occur when individuals have a goal that can be fulfilled by confirmation of the placebo expectation, and the role of motivation is demonstrated across a variety of symptom domains and via 4 different goal activation techniques.

Drug-related information generates placebo and nocebo responses that modify the drug response.

OBJECTIVE Administration of the muscle relaxant carisoprodol and placebo was crossed with information that was agonistic or antagonistic to the effect of carisoprodol. It was investigated whether

The placebo puzzle: putting together the pieces.

  • Steve Stewart-Williams
  • Psychology
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association
  • 2004
This article outlines and assesses the main theories of the placebo effect and suggests how they might sit together in a larger model of placebo etiology. Among the approaches considered are
...